Azelaic acid vs tretinoin for acne is not a clean winner-takes-all contest. A six-month head-to-head trial found similar improvement in comedonal acne, while azelaic acid caused less redness and scaling. Tretinoin belongs to a class with stronger guideline support. Azelaic acid has a weaker recommendation but may fit people who prioritize tolerability. The choice depends on acne type, pregnancy plans, access and your prescriber’s judgment.
| Decision point | Azelaic acid | Tretinoin |
|---|---|---|
| Direct evidence | 20% cream produced similar comedonal-acne improvement to 0.05% tretinoin cream in one 289-person trial. | The same trial found no statistically significant response difference, but it did not prove universal equivalence. |
| Evidence fit | The US 20% cream label covers mild-to-moderate inflammatory acne. AAD support is conditional. | AAD strongly recommends topical retinoids as a class. The US 0.05% cream label covers acne vulgaris. |
| Time to judge | US and UK 20% cream labels describe visible improvement around four weeks, with further gains over months. | The US 0.05% cream label says benefit can appear within weeks, but definite improvement may take longer than six weeks. |
| Common tradeoff | Burning, stinging, itching and dryness can occur. The direct trial found less persistent redness and scaling. | Redness, peeling, dryness and sun sensitivity are common practical limits. An early apparent flare can occur. |
| Prescription status | US Azelex 20% and UK Skinoren 20% are prescription medicines. Lower-strength cosmetic products are different formulations. | The verified US 0.05% cream is prescription-only. The verified UK tretinoin-clindamycin gel is also prescription-only. |
| Pregnancy | Not a self-treatment choice. US and UK 20% cream labels advise caution because controlled human data are lacking. | UK guidance contraindicates topical retinoids during pregnancy and pregnancy planning. The US label also carries a fetal-risk warning. |
DailyMed and UK product summaries were checked on 12 November 2026. Azelex is a US prescription cream with 20% azelaic acid. The verified US generic is a prescription cream with 0.05% tretinoin. Skinoren is a UK prescription cream with 20% azelaic acid. Treclin is a UK prescription gel with 0.025% tretinoin and 1% clindamycin, so its antibiotic changes the comparison.
What did the direct comparison actually find?
Yes, researchers have compared these medicines directly. Acta Dermato-Venereologica Supplementum published the trial by Katsambas, Graupe and Stratigos in 1989. They randomly assigned 289 people with mainly comedonal acne to 20% azelaic acid cream or 0.05% tretinoin cream. The study was single-blind, ran six months and had 71% completion. Its protocol increased both creams to twice daily after two weeks. The current US tretinoin label says once daily, which limits a modern tolerability comparison. The trial also does not settle inflammatory acne, lower azelaic strengths or newer tretinoin vehicles.
Good-to-excellent comedone reduction occurred in 65% of the azelaic group and 69% of the tretinoin group. The difference was not statistically significant. Subjective good-to-excellent overall improvement was also close: 59% versus 62%.
Tolerability separated them more clearly. Persistent redness affected 17.5% with azelaic acid and 27.4% with tretinoin. Persistent scaling affected 16.8% and 28.8%, respectively. Irritation caused 6.3% of azelaic users and 9.6% of tretinoin users to leave the trial.
Liu and colleagues published a 2020 Cochrane Database review of 49 randomised trials with 3,880 reported participants. Only one 289-person trial supplied the self-rated response comparison between azelaic acid and tretinoin. Its risk ratio was 0.94, with a 95% confidence interval from 0.78 to 1.14. The reviewers rated that evidence moderate and found probably little or no response difference. That interval still allows outcomes favouring either medicine. It is not proof that they work identically.
Why guidelines still lean toward topical retinoids
The American Academy of Dermatology’s 2024 guideline strongly recommends topical retinoids as a class. It gives azelaic acid a conditional recommendation. Those grades cover each option’s wider evidence base. They do not show that tretinoin beat azelaic acid in the direct trial.
This distinction matters. Tretinoin has stronger class-level backing, while azelaic acid has a useful but smaller evidence base. Neither is automatically best for every breakout pattern. If your prescriber is considering another retinoid, the adapalene and tretinoin comparison answers that separate choice.
Formulation also changes tolerance. Cream, gel and strength cannot be treated as interchangeable labels. Compare the tretinoin cream and gel tradeoffs or the evidence for different azelaic acid strengths before generalising from one study.
How long should either option get?
The US Azelex 20% label says most patients with inflammatory lesions improve within four weeks. The UK Skinoren 20% label also places distinct improvement at about four weeks. It says the best results can take several months.
The US 0.05% tretinoin cream label says results may appear after two to three weeks. Definite benefit can take longer than six weeks. It also warns that inflammatory lesions may look worse early as previously unseen lesions surface.
These label timelines come from different evidence and should not become a speed contest. NICE reviews first-line acne treatment after a 12-week course. A few rough mornings do not establish failure. Your review date should come from the clinician managing the prescription.
A simple routine can reduce avoidable irritation
No routine can promise zero irritation. Keep the support steps plain, then follow the prescribed medicine exactly as directed.
- Wash with a mild cleanser and lukewarm water. Do not scrub the spots.
- Let the skin dry, then use the medicine exactly as its label and prescriber direct.
- Use a plain moisturiser that does not sting or contain another acne active.
- Protect treated skin from excess sun. The tretinoin label advises sunscreen and protective clothing.
- Avoid adding peels, abrasive cleansers, drying toners or another retinoid without checking first.
The US tretinoin label warns that drying or abrasive products can compound irritation. NICE says clinicians may use alternate-day or short-contact application when starting irritating topical treatments. That is a clinician-led adjustment, not a cue to change a prescription yourself.
Stinging, dryness and mild peeling can happen. Severe swelling, blistering, crusting or persistent pain needs prompt advice from the prescriber. More product will not clear acne faster, and the tretinoin label says excess use can increase redness and discomfort.
Pregnancy changes the decision
UK NICE guidance contraindicates topical retinoids during pregnancy and while planning pregnancy. The current UK Treclin label, for tretinoin combined with clindamycin, carries the same contraindication. It is a prescription product, not a stand-in for plain tretinoin.
The US 0.05% tretinoin cream label says controlled pregnancy studies are lacking. It warns that use requires weighing potential benefit against fetal risk. Azelaic acid is not an automatic green light. The US Azelex label says use during pregnancy only if clearly needed, while the UK Skinoren label advises caution.
If you are pregnant, trying to conceive or breastfeeding, let a clinician choose the treatment. Do not start, stop or switch a prescription from an online comparison.
How to make the decision with a clinician
Start with the lesions you actually have. Mostly blackheads and whiteheads make the old head-to-head trial more relevant. Mild-to-moderate inflamed spots make the US azelaic acid indication more relevant. Mixed acne often needs more than a one-product contest, which the AAD guideline recognises through multimodal treatment.
Ask which exact formulation is available, what irritation is acceptable and when progress will be reviewed. Mention eczema, current actives, pregnancy plans and previous reactions. Those details can change the choice more than the ingredient name.
Painful nodules, new scars, widespread acne or marked distress need professional assessment. So does acne that has not meaningfully improved after the planned course. The guide to cystic acne and dermatologist care explains why deep lesions should not be managed by trial-and-error switching.
Oscar Nascimento
Editorial writer, GlowUp Face
Oscar writes about evidence-based skin care, healthcare, looksmaxxing, and the social and economic research surrounding appearance.
Full profile and all articles →
